Targeting Ferroptosis: Pathological Mechanism and Treatment of Ischemia-Reperfusion Injury
Ischemia-reperfusion (I/R) is a pathological process that occurs in many organs and diseases. Reperfusion, recovery of blood flow, and reoxygenation often lead to reperfusion injury. Drug therapy and early reperfusion therapy can reduce tissue injury and cell necrosis caused by ischemia, leading to...
Saved in:
Main Authors: | Xinye Li, Ning Ma, Juping Xu, Yanchi Zhang, Pan Yang, Xin Su, Yanfeng Xing, Na An, Fan Yang, Guoxia Zhang, Lijing Zhang, Yanwei Xing |
---|---|
Format: | article |
Language: | EN |
Published: |
Hindawi Limited
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/f913e1ed6d1e4623b47ba4e986f43a48 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Irisin: A Promising Target for Ischemia-Reperfusion Injury Therapy
by: Yani Wang, et al.
Published: (2021) -
Ubiquitin-Specific Protease 29 Exacerbates Cerebral Ischemia-Reperfusion Injury in Mice
by: Jia-Bao Hou, et al.
Published: (2021) -
Emerging Pathological Engagement of Ferroptosis in Gut Diseases
by: Weihua Gao, et al.
Published: (2021) -
Mitochondrial Transplantation Attenuates Cerebral Ischemia-Reperfusion Injury: Possible Involvement of Mitochondrial Component Separation
by: Qiang Xie, et al.
Published: (2021) -
Tubeimoside I Ameliorates Myocardial Ischemia-Reperfusion Injury through SIRT3-Dependent Regulation of Oxidative Stress and Apoptosis
by: Dingyi Lv, et al.
Published: (2021)